AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Group 1 - The biotech industry has experienced significant fluctuations this year, characterized by both high and low points [1] - There has been a recent increase in M&A activity within the biotech sector, indicating a shift in market dynamics [1] - The company is evaluating its approach to capital deployment, particularly in relation to larger scale transactions versus smaller in-licensing deals [2]